摘要
目的:通过观察早搏灵胶囊治疗冠心病阵发性房颤的临床疗效,讨论其作用机理。方法:选择60例冠心病阵发性房颤气阴两虚,兼心血瘀阻型患者,随机分为两组,每组各30例,治疗组服用早搏灵胶囊,对照组服用可达龙,观察4周。结果:(1)两组房颤疗效比较:两组疗效无显著性差异(P>0.05)。(2)两组房颤发作次数:两组均减少房颤发作次数(P<0.05),治疗后两组比较无显著性差异(P>0.05)。(3)治疗前后24 h总心搏比较:治疗组无显著性差异(P>0.05),对照组有显著性差异(P<0.05)。结论:早搏灵胶囊能显著减少冠心病阵发性房颤(气阴两虚证兼心血瘀阻)患者房颤的发作次数,且对心率无明显影响。
Objective：Discuss the mechanism of Zaoboling Capsule on the patients with coronary heart disease paroxysmal atrial fibrillation,by observing its clinical efficacy. Methods：The 60 patients with coronary heart disease PAF patients（TCM is both Qi and Yin deficiency,blood stasis）were randomly divided into treatment group（treated with Zaoboling Capsule）and control group（treated with cordarone）,30 patients in each group,the course of treatment was 4 weeks. Results：（1）Compared the clinical efficacy of the two groups of paroxysmal atrial fibrillation：there was no significant difference after treatment between two groups（P〉0.05）.（2）Compared with before treatment,the recrudescence times of PAF in both groups had significant difference（P〈0.05）. While there was no significant difference after treatment between two groups（P〉0.05）.（3）Before and after treatment,the treatment group had no significant difference of the heat rates in 24 hours（P〉0.05）,while it was significantly different in control group（P〈0.05）.Conclusion：The Zaoboling Capsule can significantly reduce coronary heart disease paroxysmal atrial fibrillation（Qi and Yin deficiency,blood stasis）episodes of atrial fibrillation,but no significant effect on the heart rate.
出处
《辽宁中医药大学学报》
CAS
2015年第11期17-18,共2页
Journal of Liaoning University of Traditional Chinese Medicine
基金
教育部春晖计划合作与交流项目(Z2010046)
关键词
早搏灵胶囊
阵发性房颤
动态心电图
Zaoboling Capsule
paroxysmal atrial fibrillation
dynamic electrocardiogram
